Literature DB >> 1473564

Comparison of the anticonstrictor action of dihydropyridines (nimodipine and nicardipine) and Mg2+ in isolated human cerebral arteries.

E Alborch1, J B Salom, A J Perales, G Torregrosa, F J Miranda, J A Alabadí, T Jover.   

Abstract

The isometric tension recorded from ring segments of branches of human middle cerebral artery was the parameter used to study the inhibition of spasmogen-induced contractions as model for cerebral vasospasm. Concentration-response curves to 5-hydroxytryptamine (10(-9)-3 x 10(-5) M) and prostaglandin F2 alpha (10(-7)-3 x 10(-5) M) were inhibited in Ca(2+)-free medium and in Ca(2+)-free medium to which EGTA (1 mM) had been added, respectively. Nimodipine (10(-7), 10(-5) M), nicardipine (10(-7), 10(-5) M) and Mg2+ (magnesium sulfate 10(-4), 10(-2) M) inhibited the 5-HT-elicited contractions, and this inhibition was similar for the highest concentrations tested. In contrast, nimodipine and nicardipine were more effective than Mg2+ to inhibit the prostaglandin F2 alpha-elicited contractions. Nimodipine (10(-9)-10(-5) M), nicardipine (10(-9)-10(-5) M) and Mg2+ (10(-5)-3 x 10(-2) M) relaxed the arteries precontracted with PGF2 alpha (10(-5) M), but nicardipine was the most potent relaxant drug. Because 5-hydroxytryptamine and prostaglandin F2 alpha may be involved in the pathogenesis of cerebral vasospasm, nimodipine, nicardipine, and Mg2+ could be used in the pharmacological treatment of this disorder. However, dihydropyridines (particularly nicardipine) are more potent anticonstrictors than Mg2+.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1473564     DOI: 10.1016/0014-2999(92)90289-g

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  The safety and feasibility of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in aneurysmal subarachnoid hemorrhage.

Authors:  Abutaher M Yahia; Jawad F Kirmani; Adnan I Qureshi; Lee R Guterman; L Nelson Hopkins
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 2.  Magnesium for neuroprotection in ischaemic stroke: rationale for use and evidence of effectiveness.

Authors:  K W Muir
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

3.  Modulation of endothelin-1-induced contractions by magnesium/calcium in porcine ciliary arteries.

Authors:  E S Dettmann; T F Lüscher; J Flammer; I O Haefliger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1998-01       Impact factor: 3.117

4.  Magnesium sulfate treatment improves outcome in patients with subarachnoid hemorrhage: a meta-analysis study.

Authors:  Bin Huang; Nikan H Khatibi; Linyan Tong; Pengcheng Yan; Peng Xie; John H Zhang
Journal:  Transl Stroke Res       Date:  2010-06       Impact factor: 6.829

5.  Duration of Vasodilatory Action After Intra-arterial Infusions of Calcium Channel Blockers in Animal Model of Cerebral Vasospasm.

Authors:  Jeongwook Lim; Young Dae Cho; Hyon-Jo Kwon; Soo Hyoung Byoun; Hyeon-Song Koh; Bumsoo Park; Seung-Won Choi
Journal:  Neurocrit Care       Date:  2020-09-25       Impact factor: 3.210

Review 6.  Fibromyalgia syndrome: a pain modulation disorder related to altered limbic function?

Authors:  J A Goldstein
Journal:  Baillieres Clin Rheumatol       Date:  1994-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.